supply-chain disruption — e.g. “Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.” (Spain)
Recent shortage history
Spain: resolved 25 Feb 2026 (began 3 Feb 2026)
Spain: resolved 4 Dec 2025 (began 13 Aug 2025)
Spain: resolved 27 Nov 2025 (began 10 Aug 2025)
Frequently asked questions
Is Etoricoxib Viatris currently in shortage?
Yes. As of the latest regulator updates, Etoricoxib Viatris has 1 active shortage notice across 1 country (Spain). Status is refreshed daily from official regulatory sources.
Why is Etoricoxib Viatris in shortage?
Regulators attribute the current Etoricoxib Viatris shortages to supply-chain disruption. The exact cause varies by country and product — each notice on this page links to the official source.
When will the Etoricoxib Viatris shortage be resolved?
Regulator-estimated resolution dates currently range from 7 Sept 2026 to 7 Sept 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Where does this Etoricoxib Viatris shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Data on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.